Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

NCT04991194 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

61

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: BIA 5-1058

Sponsor

Bial - Portela C S.A.